Abstract:Objective To determine the pregnancy outcome in women with endometrial atypical hyperplasia after conservative treatment.Methods From March 1,2009 to August 31,2012,four patients with endometrial atypical hyperplasia who had received satisfactory conservative therapy were treated in the Center of Reproduction and Genetics,Peking University First Hospital.All patients achieved clinical intrauterine pregnancies.One patient became pregnant twice.We reviewed the data of five pregnancies in these four patients.The data for each patient were recorded,including endometrium pathology diagnoses before pregnancy,fertilitysparing approaches,assisted reproductive technologies for conceiving,pregnancy complications,termination time of their pregnancies,the delivery mode and the postpartum status.Results All the patients underwent dilatation and curettage.The endometrium pathology diagnoses in each patient were complex mild-moderate atypical hyperplasia,complex moderate atypical hyperplasia,complex atypical hyperplasia and extensive atypical hyperplasia with endometrial intraepithelial neoplasia (EIN),respectively.Cases 1,2 and 3 received medroxyprogesterone acetate 250 mg/d for eleven,eight and four months,respectively.Case 4 received megestrol acetate 160 mg/d for eight months.Endometrial atypical hyperplasia was not found by dilatation and curettage after treatment.Case 1 achieved a singleton pregnancy following follicle stimulating hormone-induced ovulation three months after drug withdrawal.Case 2 and 4 achicvcd a singleton pregnancy by inspection ovulation the month after drug withdrawal.The first pregnancy in Case 2 resulted in embryo diapause at nine weeks of gestation,and the second singleton pregnancy by inspection ovulation occurred six months after curettage.Case 3 failed to conceive following clomiphene citrate-induced ovulation for two months.The patient underwent repeat dilatation and curettage due to abnormal uterine bleeding and was diagnosed with EIN.She was retreated with megestrol acetate 160 mg/d for eight months.The patient then received in vitro fertilization and embryo transfer and achieved a twin pregnancy,but aborted at 22+6 weeks.Case 1,2 (the second pregnancy) and 4 achieved full-term pregnancy.In five pregnancies,one case underwent embryo diapause in early pregnancy,one case underwent late pregnancy abortion,and three cases achieved full term pregnancies and three healthy infants.Conclusions Patients with endometrial atypical hyperplasia who receive conservative treatment can conceive successfully and have an optimistic pregnancy outcome after appropriate assisted reproductive technology.However,complications,such as abortion,are more common in these patients.Close monitoring is required during pregnancy to determine abnormal conditions and administer appropriate and timely treatment.

Analysis of the Clinical Outcome of in Vitro Fertilization in Infertility Patients with Conservative Treatment of Atypical Endometrial Hyperplasia and Early Well-Differentiated Endometrial Adenocarcinoma

Outcome of Conservative Treatment and Subsequent Assisted Reproductive Technology for Patients with Early-Stage Endometrial Adenocarcinoma and Poor Fertility Potential

Outcome of in vitro fertilization in endometriosis-associated infertility: a 5-year database cohort study.

Fertility-preserving Treatment and Pregnancy Outcomes in the Early Stage of Endometrial Carcinoma.

[Effects of Pathological Assessment of Endometrial Tissue in Fertility-Sparing Treatment with Progestin for Endometrial Carcinoma of Stage I a and Complex Atypical Hyperplasia].

[Analysis of Pregnancy Outcome after Fertility-Preserving Treatment among Women with Atypical Endometrial Hyperplasia or Endometrial Carcinoma].

Analysis of IVF/ICSI Outcomes in Infertile Women with Early-Stage Endometrial Cancer and Atypical Endometrial Hyperplasia after Conservative Treatment

[Analysis of Prognosis and Pregnancy Outcomes of Fertility-Preserving Treatment for Patients with Stage Ⅰa, Grade 2 Endometrial Cancer].

Analysis of Factors Associated With Recurrence of Early-Stage Endometrial Carcinoma and Atypical Endometrial Hyperplasia in Infertile Women After In Vitro Fertilization Treatment

The Optimal Time for the Initiation of in Vitro Fertilization and Embryo Transfer among Women with Atypical Endometrial Hyperplasia and Endometrial Carcinoma Receiving Fertility-Sparing Treatment

[Clinical Analysis of Fertility-Sparing Therapy of Patients with Complex Atypical Hyperplasia and Endometrial Cancer].

Treatment outcomes of infertile women with endometrial hyperplasia undergoing their first IVF/ICSI cycle: A matched-pair study

Analysis of assisted reproductive outcomes in patients with atypical endometrial hyperplasia and early-stage endometrial cancer after fertility-sparing treatment

Analysis of Pregnancy Outcome in Women with Endometrial Atypical Hyperplasia after Conservative Treatment

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy

Use of Clinicopathological Factors to Predict Prognosis of Fertility-Sparing Treatment for Endometrial Endometrioid Carcinoma and Atypical Hyperplasia

Analysis of Risk Factors for Recurrence in Infertile Endometrial Cancer Patients after in Vitro Fertilization Treatment

Clinical Features and Outcome of 15 Patients with Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Received Primary Fertility-Sparing Therapy Followed by Hysterectomy

Pregnancy outcomes in infertile patients with endometrial hyperplasia with or without atypia undergoing in vitro fertilization: the early-follicular long protocol is superior to midluteal long protocol

Fertility-preserving Treatment Outcome in Endometrial Cancer or Atypical Hyperplasia Patients with Polycystic Ovary Syndrome.

Analysis of Immunohistochemical Characteristics and Recurrence after Complete Remission with Fertility Preservation Treatment in Patients with Endometrial Carcinoma and Endometrial a Typical Hyperplasia